Common Contracts
14 similar null contracts by Orgenesis Inc., Ardelyx, Inc., Value Exchange International, Inc.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • March 7th, 2024 • Pharmaceutical preparations
This Warrant is issued to XXXX, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 3, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • March 7th, 2024 • Pharmaceutical preparations
This Warrant is issued to XXXX, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 3, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • January 5th, 2024 • Pharmaceutical preparations
This Warrant is issued to Yehuda Nir, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Loan Extension Agreement, dated as of January 1, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Loan Extension Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • January 5th, 2024 • Pharmaceutical preparations
This Warrant is issued to Aharon Lukach, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Loan Extension Agreement, dated as of January 1, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Loan Extension Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VALUE EXCHANGE INTERNATIONAL, INC.Value Exchange International, Inc. • February 2nd, 2023 • Services-miscellaneous business services
This Warrant is issued to ________________________________, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Credit Agreement, dated as of January 27, 2023, among Value Exchange International, Inc., a Nevada corporation (the “Company”), the Purchaser and certain other party thereto (the “Convertible Credit Agreement”) and is subject to the terms and conditions of the Convertible Credit Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • October 27th, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to Yehuda Nir, or its registered assigns (including any successors or assigns, the “Lender”), pursuant to that certain Extension to the Convertible Loan Agreement, dated as of October 23, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Lender thereunder (the “Extenstion”) and is subject to the terms and conditions of the Extenstion.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • October 27th, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to Ricky Neumann, or its registered assigns (including any successors or assigns, the “Lender”), pursuant to that certain Convertible Loan Extension Agreement, dated as of October 23, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Lender thereunder (the “Extenstion”) and is subject to the terms and conditions of the Extenstion.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • May 23rd, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to Ricky Neumann, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Loan Agreement, dated as of May 19, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Convertible Loan Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • May 17th, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Loan Agreement, dated as of May 17, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Convertible Loan Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • April 25th, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Loan Agreement, dated as of April 21, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Convertible Loan Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • April 5th, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 30, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • January 22nd, 2020 • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the "Purchaser"), pursuant to that certain Securities Purchase Agreement, dated as of January 20, 2020, among Orgenesis Inc., a Nevada corporation (the "Company"), the Purchaser and certain other purchasers thereunder (the "Purchase Agreement") and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ARDELYX, INC.Ardelyx, Inc. • July 13th, 2015 • Pharmaceutical preparations • California
This Warrant is issued to , or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of June 2, 2015, among Ardelyx, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ARDELYX, INC.Ardelyx, Inc. • July 13th, 2015 • Pharmaceutical preparations • California
This Warrant is issued to , or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of June 2, 2015, among Ardelyx, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
